Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study

Department of Dental Public Health, University of Helsinki, Helsinki, Uusimaa, Finland
International Journal of Obesity (Impact Factor: 5.39). 07/2007; 31(7):1126-33. DOI: 10.1038/sj.ijo.0803561
Source: PubMed

ABSTRACT To determine if levels of the adipocyte-derived hormone, leptin, predict the development of type 2 diabetes.
Population-based surveys were undertaken in the multiethnic nation of Mauritius in 1987, 1992 and 1998. Questionnaires, anthropometric measurements, and a 2-h 75-g oral glucose tolerance test were included. A cohort of 2330 participants who were free of diabetes, aged 25-79 years in 1987, and who were followed-up in 1992 and 1998 was studied. Serum leptin was measured in baseline samples. Glucose tolerance was classified according to WHO (World Health Organization) 1999 criteria.
In total, 456 subjects developed diabetes over 11 years with similar incidences in all ethnic groups (P=0.2). Baseline leptin correlated positively with anthropometric measurements, fasting and postload insulin and homeostasis model assessment indices (all P<0.001), and inversely with subsequent weight increase. Participants with incident diabetes had higher serum levels of leptin at baseline than those remaining nondiabetic (P<0.001). After adjustment for confounders, high leptin levels and high leptin/body mass index ratio were independently associated with incident diabetes over 11 years in men (odds ratio for top versus bottom quartile of leptin 2.18; 95% CI: 1.09-4.35), but not in women.
We conclude that high leptin levels are associated with the future development of diabetes, and the association is independent of other factors in men, but not in women.

  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND/OBJECTIVES: Most of the interventional studies have investigated the impact of the diet on adiponectin and leptin concentrations only in men or in women. Consequently, it is still unknown whether the consumption of a healthy diet influences in a sex-specific manner these adipocytokines. We examined sex differences in the effects of the Mediterranean diet (MedDiet) on adiponectin and leptin concentrations, and determined whether changes in these adipocytokines are associated with changes in cardiovascular risk factors in both sexes. SUBJECTS/METHODS: Participants were 38 men and 32 premenopausal women (24-53 years) with slightly elevated low-density lipoprotein cholestrol concentrations (3.4-4.9 mmol/l) or total cholesterol/high-density lipoprotein cholestrol (HDL-C) >= 5.0. Adiponectin, leptin and cardiovascular risk factors were measured before and after a 4-week fully controlled isoenergetic MedDiet. RESULTS: Adiponectin concentration decreased in response to the MedDiet, but this decrease reached statistical significance only in men (P < 0.001 for men and P=0.260 for women; sex-by-time interaction, P=0.072). Adjustments for body weight or waist circumference did not change results obtained. Changes in adiponectin were positively associated with concomitant variations in HDL-C in men (r= 0.52, P=0.003) and with variations in apolipoprotein A-1 and insulin sensitivity as calculated by both the homeostasis model assessment index for insulin sensitivity and Cederholm indices in women (respectively, r=0.44, P=0.021; r=0.79, P < 0.001 and r=0.47, P=0.020). The MedDiet had no impact on leptin and the leptin-to-adiponectin ratio in both sexes. CONCLUSIONS: Results suggest a sex difference in adiponectin response to the short-term consumption of the MedDiet, with only men experiencing a decrease. Also sex-specific patterns of associations between changes in adiponectin concentration and changes in cardiovascular risk factors were observed.
    European journal of clinical nutrition 03/2014; 68(5). DOI:10.1038/ejcn.2014.27 · 2.95 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Soy isoflavones have received great attention for their beneficial effects on health and disease, i.e., in patients with diabetes. Equol is a biologically active isoflavone-related metabolite with interindividual differences in its production. The current study investigated the relationship between an equol-producing state and the levels of adipocytokine markers in a prediabetic and diabetic population. A total of 79 subjects (34 males/45 females) in a prediabetic or diabetic state recruited from the general population were examined regarding their ability to produce equol using urine samples. Clinical data, such as age, smoking as well as anthropometric and biochemical variables, including body mass index (BMI), lipids, insulin, glucose, hemoglobin A1c, leptin and adiponectin, were recorded. Equol producers exhibited lower leptin and leptin/BMI than non-producers among females. Simple correlation tests and stepwise multiple regression analyses revealed a significant inverse correlation between the leptin/BMI and equol-production. This relationship was not found in males. Female equol producers can have favorable metabolic traits in relation to leptin metabolism in this population. Further studies are needed to confirm these results.
    Annales d Endocrinologie 03/2014; DOI:10.1016/j.ando.2014.01.003 · 0.66 Impact Factor

Full-text (2 Sources)

Available from
May 30, 2014